I went out on a limb last week, and now it’s time to see how that decision played out.
I predicted that BlackBerry (NASDAQ: BBRY ) would close lower on the week. The hype that’s been building for months surrounding the domestic launch of the Z10 hasn’t matched the reality now that the country’s two largest carriers have the new BlackBerry device available. Still, the stock rallied earlier in the week, holding on to enough of those gains to close out the week 1.7% higher. I was wrong. I predicted that the tech-heavy Nasdaq would outperform the Dow Jones Industrial Average. (DJINDICES: ^DJI ) . This has been a tricky call lately, so how did it play out this time? Well, it didn’t. The Nasdaq got blasted for a 1.9% hit, and the Dow managed to close barely unchanged, with only a marginal downtick. I was wrong. My final call was for Conn’s (NASDAQ: CONN ) to beat Wall Street’s quarterly profit target. The consumer-electronics retailer has been able to sidestep the stagnancy taking place at larger chains because Conn’s offers larger items, including mattresses and lawn-maintenance equipment, that can’t be easily replaced online. The company also has been beating Wall Street estimates consistently over the past year. Analysts were looking for a profit of $0.55 a share during the quarter, and it came through with net income of $0.54. I was wrong.
I missed on all three. That doesn’t happen often, and I know I can do better. So let me once again whip out my trusty, dusty, and occasionally accurate crystal ball to make three calls that may play out over the next few trading days.
Top 5 Managed Healthcare Stocks To Buy Right Now: Synergy Pharmaceuticals Inc (SGYP)
Synergy Pharmaceuticals, Inc., incorporated on February 11, 1992, is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company’s lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C). It is also developing SP-333, the second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis (UC). The Company’s active pharmaceutical ingredients (APIs) and the final formulated drug products are manufactured for it by third party contractors.
As of December 31, 2011, the Company was developing plecanatide, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. Plecanatide is an agonist of GC-C receptor. A s of December 31, 2011, the Company was dosing patients in an 800-patient Phase II/III clinical trial of plecanatide to treat. It is also developing a second generation GC-C receptor analog, SP-333, which is in pre-clinical development for the treatment of gastrointestinal inflammatory diseases. SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone.
The Company competes with Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.
- [By Monica Gerson]
Time Warner Cable (NYSE: TWC) reported a drop in its third-quarter profit. Time Warner Cable’s quarterly profit fell to $532 million, or $1.84 per share, from $808 million, or $2.60 per share, in the year-ago period. To read the full news, click here. Synergy Pharmaceuticals (NASDAQ: SGYP) today announced the start of a phase 2 clinical trial to evaluate the safety and efficacy of SP-333, its second-generation GC-C agonist and once-daily oral treatment, in adult patients with opioid-induced constipation (OIC). To read the full news, click here. Cigna (NYSE: CI) reported a 19% rise in its third-quarter earnings and lifted its full-year earnings outlook. To read the full news, click here. Charm Communications (NASDAQ: CHRM) announced today that the special committee of the Company’s board of directors, consisting of independent directors Mr. Zhan Wang, Mr. Andrew J. Rickards and Mr. Gang Chen, has retained China Renaissance Securities (Hong Kong) Limited as its financial advisor and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP as its legal advisor. To read the full news, click here.
Posted-In: Bank of America US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
- [By Sean Williams]
Finally, Synergy Pharmaceuticals (NASDAQ: SGYP ) may have had the wildest week of them all. Synergy’s share price spiked 16% on Tuesday as an analyst at Cantor Fitzgerald raised her peak sales estimate for plecanatide, the company’s midstage drug for chronic idiopathic constipation and irritable bowel syndrome with constipation, to $1.58 billion from $1.05 billion, as clinical data has been stronger than expected. However, the company didn’t return the favor to shareholders by — the very next day, mind you – announcing a secondary offering of 16.375 million shares. The downside of clinical-stage companies is the always apparent risk of dilution. Shares have lost 25% since their Tuesday close.
Top 5 Managed Healthcare Stocks To Buy Right Now: Constellium NV (CSTM)
Constellium N.V., formerly Constellium Holdco BV, is a Netherlands-based company, which is engaged in the manufacture of aluminum products and solutions. The Company is a supplier of such sectors as: aerospace, automotive and packaging. Constellium Holdco BV offers plates, sheet and coil, precision casting, cockpit carriers for vehicles, vehicle safety components, profiles, as well as tubes and bars, among others. Its main customers include: Airbus, Boeing, Embraer, Audi, BMW, Citroen, Renault, Mercedes Benz, Jaguar and others. The Company is active domestically and abroad, including North America, Europe and Asia. Advisors’ Opinion:
- [By GuruFocus]
George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) – 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) – 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) – 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) – 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) – 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.2 7, with an estimated
Top 5 Managed Healthcare Stocks To Buy Right Now: SGOCO Group Ltd(SGOC)
SGOCO Group, Ltd. designs, manufactures, and distributes liquid crystal display (LCD) consumer products in the People?s Republic of China and internationally. Its products include LCD personal computer monitors, LCD televisions, light emitting diode back-light modules, and application-specific LCD systems. The company also provides custom manufacturing services for application-specific LCD monitors, such as rotating screens, CCTV monitors for security systems, billboard monitors for advertising and public notice systems, and touch screens for non-keyed entries. SGOCO Group, Ltd. sells its products under the SGOCO, Edge 10, POVIZON, and No. 10 brands through a network of independent retail outlets operating under the ?SGOCO Image? name. The company offers its products to industry clients, such as medical centers, educational institutions, government complexes, public emergency response systems, and corporate offices, as well as to retail customers. As of December 31, 201 0, it had 603 retail stores covering 14 provinces and municipalities in the People?s Republic of China. The company, formerly known as SGOCO Technology, Ltd., was founded in 2006 and is based in Beijing, China.
- [By John Udovich]
Small cap display stock SGOCO Group Ltd (NASDAQ: SGOC) just sank 27.89% after reporting earnings, meaning its worth taking a closer look at it along with some other innovative display stocks like Corning Incorporated (NYSE: GLW) and Universal Display Corporation (NASDAQ: OLED). After all, just about every new consumer gadget along with cars and even appliances are incorporating display technology. I should also mention that we have had Corning Incorporated in our SmallCap Network Elite Opportunity (SCN EO) portfolio since early December (we are up around 29.20%) as we believe the company is in the sweet spot for next generation flexible screens and mobile wearables.
- [By John Udovich]
Large cap glass and ceramics technology stock Corning Incorporated (NYSE: GLW) has put in a good performance since announcing a deal with Samsung back in October, meaning its probably time to take a closer look at the stock along with the performance of potential peers (either upstream or downstream on the OLED and liquid crystal display side of the glass business) like small cap players like Daktronics, Inc (NASDAQ: DAKT), SGOCO Group Ltd (NASDAQ: SGOC) and Universal Display Corporation (NASDAQ: OLED). I should note that we have recently added Corning Incorporated to our SmallCap Network Elite Opportunity (SCN EO) portfolio because we believe the company’s position as it relates to glass and ceramics puts it in a sweet spot for the next generation flexible screens and mobile wearables. But that’s not all there is to like about this stock.
Top 5 Managed Healthcare Stocks To Buy Right Now: CNinsure Inc.(CISG)
CNinsure Inc., together with its subsidiaries, provides insurance brokerage and agency services, and insurance claims adjusting services in the People?s Republic of China. The company offers property, casualty, and life insurance products underwritten by domestic and foreign insurance companies operating in China. Its property and casualty insurance products include automobile, individual accident, commercial property, homeowner, cargo, hull, liability, and construction insurance; and life insurance products comprise individual whole life insurance, term life insurance, education annuity, and health insurance, as well as universal insurance and group life insurance. The company also offers insurance claims adjusting services, which include pre-underwriting survey, claims adjusting, disposal of residual value, loading and unloading supervision, and consulting services, as well as damage assessment, survey, authentication, and loss estimation to insurance companies and the i nsured; and value-added services to its customers in conjunction with distributing automobile insurance products. As of April 15, 2010, its distribution and service network consisted of 49 insurance agencies, 3 insurance brokerages, and 4 claims adjusting firms, with 571 sales and service outlets. The company was founded in 1998 and is headquartered in Guangzhou, the People?s Republic of China.
- [By Jake L’Ecuyer]
Financial sector was the leading decliner in the US market today. Top losers in the sector included GSV Capital (NASDAQ: GSVC), off 9.3 percent, and Cninsure (NASDAQ: CISG), down around 6.6 percent.
- [By Monica Gerson]
CNinsure (NASDAQ: CISG) is projected to post its Q4 earnings at $0.10 per share.
Ferrellgas Partners LP (NYSE: FGP) is expected to report its Q2 earnings at $0.85 per share on revenue of $722.07 million.
Top 5 Managed Healthcare Stocks To Buy Right Now: Cbeyond Inc.(CBEY)
Cbeyond, Inc. provides managed information technology (IT) and communications services to small businesses in the United States. Its services include local and long-distance voice, broadband Internet, mobile services, broadband laptop access, voicemail, email, Web hosting, fax-to-email, data backup, file-sharing, virtual private networking, and cloud servers; and cloud applications, data center infrastructure as a service, cloud private branch exchange phone systems, metro Ethernet, multi-protocol label switching, information security, administration management, and professional services to migrate and manage customer environments. It sells its products and services through direct sales; value-added resellers, local area network consultants, and other IT and communications consultants; and managed services providers, systems integrators, and software vendors. The company was formerly known as Cbeyond Communications, Inc. and changed its name to Cbeyond, Inc. in July 2006. Cbeyond, Inc. was founded in 2000 and is headquartered in Atlanta, Georgia.
- [By Lisa Levin]
Cbeyond (NASDAQ: CBEY) shares gained 38.56% to touch a new 52-week high of $9.81 after the company agreed to be acquired by Birch Communications in all-cash transaction valued at $323 million.
- [By Monica Gerson]
Cbeyond (NASDAQ: CBEY) soared 6.29% to $6.76 in the pre-market trading. Cbeyond shares have dropped 10.67% over the past 52 weeks, while the S&P 500 index has gained 26.42% in the same period.
- [By Lisa Levin]
Cbeyond (NASDAQ: CBEY) shares reached a new 52-week low of $6.07. Cbeyond’s PEG ratio is -1.19.
Swisher Hygiene (NASDAQ: SWSH) shares touched a new 52-week low of $0.732. Swisher Hygiene appointed William Pierce as its new president and CEO.